Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
213M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
-1.36M
-
Total reported value, excl. options
-
$146M
-
Value change
-
-$10.2M
-
Put/Call ratio
-
0.6
-
Number of buys
-
41
-
Number of sells
-
-36
-
Price
-
$8.37
Significant Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q4 2016
96 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") as of Q4 2016.
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 213M outstanding shares and own 8.17% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (3.22M shares), FMR LLC (2.62M shares), Versant Venture Management, LLC (2.22M shares), SV Life Sciences Advisers, LLC (1.61M shares), WELLINGTON MANAGEMENT GROUP LLP (971K shares), Polaris Venture Management Co. V, L.L.C. (789K shares), VANGUARD GROUP INC (728K shares), BlackRock Fund Advisors (575K shares), BlackRock Institutional Trust Company, N.A. (537K shares), and COLUMBUS CIRCLE INVESTORS (470K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.